- Story /
A reversal in thinking about the reversibility of liver damage is changing the field of hepatology.
- Story /
These stories offer a glimpse into the lives of people touched by a new era of medicine.
- Story /
The recently appointed leader of the Novartis’ digital research and development platform data42 is a strong believer that data and digital technologies will change the path of medical science.
- Story /
Read how a genetics postdoctoral researcher finds Huntington's mutation travels through neural circuits.
- Story /
Florencia Segal’s experiences prepared her to lead the rapid design of a large COVID-19 clinical trial.
- Story /
Novartis researchers aim to quash inflammation to treat chronic disease.
- Statement /
- Featured News /
Cell Therapies Pty Ltd has become the first approved CAR-T commercial manufacturing site in Australia, providing potentially faster access to CAR-T therapies to eligible patients in the region with life-threatening blood cancers.
Novartis global commercial CAR-T manufacturing footprint now spans four continents, bringing these transformative therapies closer to patients and healthcare professionals around the world. - Media Release /The study published in ‘Neurology and Therapy’ also shows the fatal outcomes and hospitalization rates due to COVID-19 in those treated with Kesimpta were in line with the rates in the general MS…
- Media Release /Sandoz gains significant capabilities and assets in medical and drug device development that target major growth opportunities in respiratory and complex generics Respiratory diseases are leading…
Pagination
- ‹ Previous page
- 1
- …
- 136
- 137
- 138
- 139
- 140
- 141
- 142
- …
- 265
- › Next page